Jamie Christensen - Dec 2, 2022 Form 4 Insider Report for Mirati Therapeutics, Inc. (MRTX)

Role
EVP, Chief Scientific Officer
Signature
/s/ Reena Desai, Attorney-in-Fact
Stock symbol
MRTX
Transactions as of
Dec 2, 2022
Transactions value $
-$155,667
Form type
4
Date filed
12/5/2022, 04:00 PM
Previous filing
Sep 9, 2022
Next filing
Dec 20, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction MRTX Common Stock Sale -$156K -1.73K -1.63% $90.19 104K Dec 2, 2022 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents shares sold by the Company to satisfy the tax withholding obligation associated with the vesting of a portion of the performance stock units (PSUs) granted on January 21, 2021.
F2 Includes 119 shares acquired under the ESPP Purchase on 11/30/2022